Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Jost Klawitter to Adult

This is a "connection" page, showing publications Jost Klawitter has written about Adult.

 
Connection Strength
  
 
 
0.287
  
  1. Sempio C, Campos-Palomino J, Klawitter J, Peters EN, MacNair L, Haghdoost M, Bonn-Miller M, Harrison A, Babalonis S, Huestis MA, Christians U, Klawitter J. Metabolite patterns in human urine after oral administration of highly purified ?8-THCV. Forensic Toxicol. 2026 Jul; 44(2):437-444.
    View in: PubMed
    Score: 0.047
  2. Klawitter J, Jackson MJ, Smith PH, Hopp K, Chonchol M, Gitomer BY, Cadnapaphornchai MA, Christians U, Klawitter J. Kynurenines in polycystic kidney disease. J Nephrol. 2023 01; 36(1):83-91.
    View in: PubMed
    Score: 0.036
  3. Klepacki J, Brunner N, Schmitz V, Klawitter J, Christians U, Klawitter J. Development and validation of an LC-MS/MS assay for the quantification of the trans-methylation pathway intermediates S-adenosylmethionine and S-adenosylhomocysteine in human plasma. Clin Chim Acta. 2013 Jun 05; 421:91-7.
    View in: PubMed
    Score: 0.019
  4. Klawitter J, Haschke M, Kahle C, Dingmann C, Klawitter J, Leibfritz D, Christians U. Toxicodynamic effects of ciclosporin are reflected by metabolite profiles in the urine of healthy individuals after a single dose. Br J Clin Pharmacol. 2010 Aug; 70(2):241-51.
    View in: PubMed
    Score: 0.016
  5. Morris AWJ, Mueller RL, Sempio C, Klawitter J, Bryan AD, Bidwell LC, Hutchison KE. Age differences in endocannabinoid tone are ameliorated after recent cannabis use. Sci Rep. 2026 Jan 24; 16(1):3483.
    View in: PubMed
    Score: 0.011
  6. Gorbenko AA, Post TE, Strugala PK, Klaassen ES, Klumpers LE, de Visser SJ, Sempio C, Klawitter J, Heuberger JAAC, Groeneveld GJ. Low-dose cannabidiol increases plasma concentrations of amitriptyline: A clinical drug-drug interaction study. Br J Clin Pharmacol. 2026 Jun; 92(6):1595-1606.
    View in: PubMed
    Score: 0.011
  7. Yee EJ, Kirsch MJ, Miller OS, Sempio C, Bainbridge J, Klawitter J, Christians U, Madsen H, McCarter MD, Gleisner AL, Gumidyala R, Lindley E, Adkins M, Semmler N, Stewart CL. Cannabis, Pain, and Complications: A Prospective Analysis of Cannabis Use, Opiate Consumption, and Postoperative Outcomes following Cancer-Related Abdominal Surgery. Ann Surg Oncol. 2026 Feb; 33(2):1370-1380.
    View in: PubMed
    Score: 0.011
  8. Strickland JC, Tilton HE, Patton NM, Vandrey R, Austin Zamarripa C, Spindle TR, Lee DC, Bergeria CL, Wolinsky D, Klawitter J, Sempio C, Campos-Palomino J, Christians U, Feldner MT, Irons JG, Bonn-Miller MO. Effect of caffeine and cannabidiol (CBD) co-administration on ?9-tetrahydrocannabinol (?9-THC) subjective effects, performance impairment, and pharmacokinetics. Neuropsychopharmacology. 2025 Nov; 50(12):1827-1835.
    View in: PubMed
    Score: 0.011
  9. Crume TL, Kim P, Shen X, Iisa E, Huestis MA, Fried P, Stickrath EH, Conageski C, Phipers JE, Kinney G, Sempio C, Klawitter J, Dufford AJ. In utero chronic cannabis exposure is associated with lower total brain volume in the first month of postnatal life. Am J Drug Alcohol Abuse. 2025; 51(4):458-470.
    View in: PubMed
    Score: 0.011
  10. Morris AWJ, Mueller RL, Sempio C, Klawitter J, Bryan AD, Bidwell LC, Hutchison KE. Effect of Cannabidiol and ?9-tetrahydrocannabinol on Anti-Inflammatory Lipid Mediator Synthesis in Humans. Cannabis Cannabinoid Res. 2025 08; 10(4):506-511.
    View in: PubMed
    Score: 0.011
  11. Moore BF, Mueller NT, Perng W, Sauder KA, Hébert ET, Hoyt AT, Wymore EM, Boyle KE, Su EJ, Shapiro ALB, Kinney G, Sempio C, Klawitter J, Christians U, Dabelea D. Impact of prenatal exposure to delta 9-tetrahydrocannabinol and cannabidiol on birth size and postnatal growth trajectories. Pediatr Obes. 2025 Jan; 20(1):e13187.
    View in: PubMed
    Score: 0.011
  12. Althoff MD, Kinney GL, Aloia MS, Sempio C, Klawitter J, Bowler RP. The impact of cannabis use proximal to sleep and cannabinoid metabolites on sleep architecture. J Clin Sleep Med. 2024 10 01; 20(10):1615-1625.
    View in: PubMed
    Score: 0.010
  13. Spindle TR, Zamarripa CA, Russo E, Pollak L, Bigelow G, Ward AM, Tompson B, Sempio C, Shokati T, Klawitter J, Christians U, Vandrey R. Vaporized D-limonene selectively mitigates the acute anxiogenic effects of ?9-tetrahydrocannabinol in healthy adults who intermittently use cannabis. Drug Alcohol Depend. 2024 04 01; 257:111267.
    View in: PubMed
    Score: 0.010
  14. Martin EL, Baker NL, Sempio C, Christians U, Klawitter J, McRae-Clark AL. Sex differences in endocannabinoid tone in a pilot study of cannabis use disorder and acute cannabis abstinence. Addict Biol. 2023 10; 28(10):e13337.
    View in: PubMed
    Score: 0.010
  15. Gibson LP, Karoly HC, Ellingson JM, Klawitter J, Sempio C, Squeri JE, Bryan AD, Bidwell LC, Hutchison KE. Effects of cannabidiol in cannabis flower: Implications for harm reduction. Addict Biol. 2022 01; 27(1):e13092.
    View in: PubMed
    Score: 0.008
  16. Gilman JM, Schmitt WA, Wheeler G, Schuster RM, Klawitter J, Sempio C, Evins AE. Variation in Cannabinoid Metabolites Present in the Urine of Adults Using Medical Cannabis Products in Massachusetts. JAMA Netw Open. 2021 04 01; 4(4):e215490.
    View in: PubMed
    Score: 0.008
  17. Bidwell LC, Ellingson JM, Karoly HC, YorkWilliams SL, Hitchcock LN, Tracy BL, Klawitter J, Sempio C, Bryan AD, Hutchison KE. Association of Naturalistic Administration of Cannabis Flower and Concentrates With Intoxication and Impairment. JAMA Psychiatry. 2020 08 01; 77(8):787-796.
    View in: PubMed
    Score: 0.008
  18. Hinckley JD, Saba L, Raymond K, Bartels K, Klawitter J, Christians U, Hopfer C. An Approach to Biomarker Discovery of Cannabis Use Utilizing Proteomic, Metabolomic, and Lipidomic Analyses. Cannabis Cannabinoid Res. 2022 02; 7(1):65-77.
    View in: PubMed
    Score: 0.008
  19. Leino AD, King EC, Jiang W, Vinks AA, Klawitter J, Christians U, Woodle ES, Alloway RR, Rohan JM. Assessment of tacrolimus intrapatient variability in stable adherent transplant recipients: Establishing baseline values. Am J Transplant. 2019 05; 19(5):1410-1420.
    View in: PubMed
    Score: 0.007
  20. Alloway RR, Vinks AA, Fukuda T, Mizuno T, King EC, Zou Y, Jiang W, Woodle ES, Tremblay S, Klawitter J, Klawitter J, Christians U. Bioequivalence between innovator and generic tacrolimus in liver and kidney transplant recipients: A randomized, crossover clinical trial. PLoS Med. 2017 Nov; 14(11):e1002428.
    View in: PubMed
    Score: 0.006
  21. Klepacki J, Klawitter J, Klawitter J, Thurman JM, Christians U. A high-performance liquid chromatography-tandem mass spectrometry-based targeted metabolomics kidney dysfunction marker panel in human urine. Clin Chim Acta. 2015 Jun 15; 446:43-53.
    View in: PubMed
    Score: 0.005
  22. Klawitter J, Reed-Gitomer BY, McFann K, Pennington A, Klawitter J, Abebe KZ, Klepacki J, Cadnapaphornchai MA, Brosnahan G, Chonchol M, Christians U, Schrier RW. Endothelial dysfunction and oxidative stress in polycystic kidney disease. Am J Physiol Renal Physiol. 2014 Dec 01; 307(11):F1198-206.
    View in: PubMed
    Score: 0.005
  23. Klawitter J, Klawitter J, McFann K, Pennington AT, Abebe KZ, Brosnahan G, Cadnapaphornchai MA, Chonchol M, Gitomer B, Christians U, Schrier RW. Bioactive lipid mediators in polycystic kidney disease. J Lipid Res. 2014 06; 55(6):1139-49.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)